Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer

First-line ibrutinib plus prednisone missed the primary endpoint in the phase 3 iNTEGRATE trial by not improving the response rate in patients with chronic graft-versus-host-disease compared with placebo plus prednisone.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

January is cervical cancer awareness month. This fourth article in a series underscores the role of the nurse or social workers in patient advocacy.

In this episode of "The Vitals," Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, shares her experience helping a patient reduce their opioid use through acupuncture treatments.

An analysis of 141 children who had prenatal exposure to maternal cancer showed promising cognitive and behavioral functions at age 9 years.

January is cervical cancer awareness month. This third article in a series highlights current cervical cancer treatment options.